Experimental pill SHY-ONC6 takes on Hard-to-Treat cancers
Disease control
Recruiting now
This early-stage trial tests an experimental oral drug called SHY-ONC6 in people with advanced or metastatic solid tumors (including breast, colon, lung, pancreatic, and others) that have stopped responding to standard treatments. The study aims to find a safe dose and check for …
Phase: PHASE1 • Sponsor: SHY Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC